As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

Description The goal of the trial was to evaluate treatment with famotidine compared with placebo among patients taking low-dose aspirin. Hypothesis Famotidine would be more effective in ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

The findings support current guidelines recommending low-dose aspirin (81 mg) as an effective preventive measure for ...

Every day, around 29 million people in the U.S. take a low dose of aspirin as a blood thinner to reduce the risk of cardiovascular diseases, such as heart attacks and strokes. Aspirin prevents blood ...

Studies of people with cancer have previously observed that those taking daily low-dose aspirin have a reduction in the spread of some cancers, such as breast, bowel, and prostate cancers ...

This cautionary approach stems from the U.S. Preventive Services Task Force’s decision to withdraw its previous recommendation for low-dose aspirin use among adults aged 50 to 59. The reversal ...

Studies of people with cancer have previously observed that those taking daily low-dose aspirin have a reduction in the spread of some cancers. Scientists have uncovered the mechanism by which ...

Prior studies showed aspirin can reduce incidence of colorectal cancer. One study presented at this year’s ASCO Gastrointestinal Cancers Symposium showed low-dose aspirin significantly reduced ...